Migraine & Neurology Clinical Trials
Run across 19 of our 30+ research sites, on one operating model and one quality system.
Request feasibilityProven neurological disease expertise, and trials enrolling today.
DM Clinical Research is a recognized leader in neurological disease clinical trials, having successfully conducted 55+ migraine & neurology studies across our national network since 2006. Our migraine & neurology program spans migraine, alzheimer's disease, parkinson's disease, multiple sclerosis, and epilepsy, backed by a 1.97M+ patient database, bilingual recruitment, and the operational rigor behind a clean inspection record.
For sponsors, that means real patient access and shortlist-ready feasibility in a high-demand area. For patients, it means access to investigational neurological disease treatments at no cost, with study care and compensation for time and travel.
Sites running migraine & neurology studies.
Albuquerque
View site details and contact →
Boston
View site details and contact →
Brooklyn
View site details and contact →
Chicago
View site details and contact →
Dallas Irving
View site details and contact →
Detroit
View site details and contact →
Houston
View site details and contact →
Indianapolis
View site details and contact →
Jersey City
View site details and contact →
Philadelphia
View site details and contact →
Phoenix
View site details and contact →
San Antonio
View site details and contact →
Seattle
View site details and contact →
Shreveport
View site details and contact →
Bradenton
View site details and contact →
Bellaire
View site details and contact →
Sugar Land Neurology
View site details and contact →
Phoenix 2nd Street
View site details and contact →
San Antonio San Saba
View site details and contact →
See if you qualify.
Answer a few short questions and our enrollment team will be in touch. Studies are at no cost to you, and you are compensated for your time.
Trouble with the form? Open it in a new tab, or call (281) 517-0550.
Advance your programme with DM.
Send the protocol synopsis and we will come back with site-level feasibility and real patient counts.
Contact business development